A research study titled, “Breast Biopsy Devices Market by procedure type, product, and guidance type - global industry analysis and forecast to 2022” published by crystal market research.
Competitive InsightsSome major players in the market are Devicor Medicals Products, Inc, C. R. Bard, Inc., OncoCyte Corporation, Stryker International, Inc., Dickinson and Company (BD), F. Hoffmann-La Roche Ltd., Hologic Inc, and Laboratory Corporation of America Holdings (Labcorp).
These organizations are extensively inclined in the enhancement of new products, decreasing the cost of production and in implementing strategies like approvals from the Food and Drug Administration, acquisitions and mergers in order to upkeep their position in the industry.
Industry Trend Analysis
The Breast Biopsy Device Market was worth USD 0.38 billion in the year 2012 and is expected to reach approximately USD 1.03 billion by 2022, while registering itself at a significant compound annual growth rate (CAGR) of 9.39% during the forecast period.
It is a diagnostic method that includes the expulsion of fluid or tissue from a suspicious region. The test needs working with guidance systems, the intent behind which is to detect an abnormality or a lump from the breast area. The varied modalities utilized as controlling systems in the location of breast tumors incorporate the ultrasound, mammography, and magnetic resonance imaging. The ultrasound section is foreseen to witness the quickest development attributable to the increasing requirement of non-radiation biopsies alongside the increasing interest for minimally invasive techniques. The expansion in the recurrence of breast cancers in women worldwide, and in addition the ascent in awareness of cancer screening programs is a portion of the components that are assessed to add to the market development over the gauged time frame. Furthermore, the various kinds of product improvement, ceaselessly propelled in the market are additionally anticipated that would positively affect this industry amid the estimated time frame.
Request to access sample report here:www.crystalmarketresearch.com/report-sample/CM10250
Regional Outlook North America is accountable for a bigger market share, primarily due to existence of key market players and prompts adoption of enhanced medical technologies, especially in countries like Canada and the U.S. According to a non-profit organization which emphasizes on breast cancer awareness – Susang Komen, in 2015 there were more than 2.3 million breast cancer cases that were diagnosed in the United States alone. Asia Pacific region is anticipated to gain lucrative market during the forecast period. This is due to the increased level of awareness amongst the population, rising disposable income, and large population. International Association of Cancer Registries stated that in 2012, more than 600,000 fresh cases of breast cancer were diagnosed in Asia and that accounted for 39% of overall breast cancers diagnosed across the world.
Market Segmentation- Breast Biopsy Devices Market By Procedure Type
Needle Breast Biopsy
Core-needle Biopsy
Fine-needle Aspiration Biopsy
Vacuum-assisted Biopsy
Open Surgical Breast Biopsy
Excisional Breast Biopsy
Incisional Breast Biopsy
By Product
Guidance Systems
Biopsy Tables
Localization Wires
Biopsy Needles
Others (Punches, Markers, Sutures)
By Guidance Type
Ultrasound-guided Breast Biopsy
Mammography-guided Stereotactic Breast Biopsy
Magnetic Resonance-guided Breast Biopsy
Others (thermography, PET)
Research Report Description with Detailed TOC on Breast Biopsy Devices Market @: www.crystalmarketresearch.com/report/breast-biopsy-device...
By Region
North America
U.S
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia Pacific
Rest of the World
Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others
Product Outlook and Trend AnalysisThe key products utilized for breast biopsy are guidance systems, localization wires, biopsy tables and needles among others. In 2015, the needles segment possessed a major share. This development is accountable to its wide relevance in the needle breast biopsy market. A large portion of the developments and progressions are seen in the products section. For example, the Stryker PreciseCore needle lets sample collection with higher accuracy and with far less risks of tissue damage included. Moreover, the guidance system product section is foreseen to witness a high development rate amid the projected time frame.
Major Table of Contents:Chapter 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
Chapter 2. Executive Summary
2.1. Key Highlights
Chapter 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Rising Number of Breast Cancer Screening Programs
3.2.1.2. Rising Demand for Minimally Invasive Surgeries
3.2.1.3. Growing Incidence of Breast Cancer
3.2.2. Restraints
3.2.2.1. Infection Risks Associated to Breast Biopsy Procedures
3.2.2.2. Strict Regulatory Issues
3.2.3. Opportunities
3.2.3.1. Technological Advancement in Breast Biopsy Procedures....CONTINUED FOR TOC
To Avail Discount, Please click On the Link @www.crystalmarketresearch.com/check-discount/CM10250
About Crystal Market Research:
Crystal Offers One Stop Solution For Market Research, Business Intelligence, And Consulting Services To Help Clients Make More Informed Decisions. It Provides Both Syndicated As Well As Customized Research Studies For Its Customers Spread Across The Globe. The Company Offers Market Intelligence Reports Across A Broad Range Of Industries Including Healthcare, Chemicals & Materials, Technology, Automotive, And Energy.
Contact Us:
Judy S,
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: Sales@Crystalmarketresearch.Com
Competitive InsightsSome major players in the market are Devicor Medicals Products, Inc, C. R. Bard, Inc., OncoCyte Corporation, Stryker International, Inc., Dickinson and Company (BD), F. Hoffmann-La Roche Ltd., Hologic Inc, and Laboratory Corporation of America Holdings (Labcorp).
These organizations are extensively inclined in the enhancement of new products, decreasing the cost of production and in implementing strategies like approvals from the Food and Drug Administration, acquisitions and mergers in order to upkeep their position in the industry.
Industry Trend Analysis
The Breast Biopsy Device Market was worth USD 0.38 billion in the year 2012 and is expected to reach approximately USD 1.03 billion by 2022, while registering itself at a significant compound annual growth rate (CAGR) of 9.39% during the forecast period.
It is a diagnostic method that includes the expulsion of fluid or tissue from a suspicious region. The test needs working with guidance systems, the intent behind which is to detect an abnormality or a lump from the breast area. The varied modalities utilized as controlling systems in the location of breast tumors incorporate the ultrasound, mammography, and magnetic resonance imaging. The ultrasound section is foreseen to witness the quickest development attributable to the increasing requirement of non-radiation biopsies alongside the increasing interest for minimally invasive techniques. The expansion in the recurrence of breast cancers in women worldwide, and in addition the ascent in awareness of cancer screening programs is a portion of the components that are assessed to add to the market development over the gauged time frame. Furthermore, the various kinds of product improvement, ceaselessly propelled in the market are additionally anticipated that would positively affect this industry amid the estimated time frame.
Request to access sample report here:www.crystalmarketresearch.com/report-sample/CM10250
Regional Outlook North America is accountable for a bigger market share, primarily due to existence of key market players and prompts adoption of enhanced medical technologies, especially in countries like Canada and the U.S. According to a non-profit organization which emphasizes on breast cancer awareness – Susang Komen, in 2015 there were more than 2.3 million breast cancer cases that were diagnosed in the United States alone. Asia Pacific region is anticipated to gain lucrative market during the forecast period. This is due to the increased level of awareness amongst the population, rising disposable income, and large population. International Association of Cancer Registries stated that in 2012, more than 600,000 fresh cases of breast cancer were diagnosed in Asia and that accounted for 39% of overall breast cancers diagnosed across the world.
Market Segmentation- Breast Biopsy Devices Market By Procedure Type
Needle Breast Biopsy
Core-needle Biopsy
Fine-needle Aspiration Biopsy
Vacuum-assisted Biopsy
Open Surgical Breast Biopsy
Excisional Breast Biopsy
Incisional Breast Biopsy
By Product
Guidance Systems
Biopsy Tables
Localization Wires
Biopsy Needles
Others (Punches, Markers, Sutures)
By Guidance Type
Ultrasound-guided Breast Biopsy
Mammography-guided Stereotactic Breast Biopsy
Magnetic Resonance-guided Breast Biopsy
Others (thermography, PET)
Research Report Description with Detailed TOC on Breast Biopsy Devices Market @: www.crystalmarketresearch.com/report/breast-biopsy-device...
By Region
North America
U.S
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
Australia
India
South Korea
Rest of Asia Pacific
Rest of the World
Brazil
South Africa
Saudi Arabia
United Arab Emirates
Others
Product Outlook and Trend AnalysisThe key products utilized for breast biopsy are guidance systems, localization wires, biopsy tables and needles among others. In 2015, the needles segment possessed a major share. This development is accountable to its wide relevance in the needle breast biopsy market. A large portion of the developments and progressions are seen in the products section. For example, the Stryker PreciseCore needle lets sample collection with higher accuracy and with far less risks of tissue damage included. Moreover, the guidance system product section is foreseen to witness a high development rate amid the projected time frame.
Major Table of Contents:Chapter 1. Introduction
1.1. Report Description
1.2. Research Methodology
1.2.1. Secondary Research
1.2.2. Primary Research
Chapter 2. Executive Summary
2.1. Key Highlights
Chapter 3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.1.1. Rising Number of Breast Cancer Screening Programs
3.2.1.2. Rising Demand for Minimally Invasive Surgeries
3.2.1.3. Growing Incidence of Breast Cancer
3.2.2. Restraints
3.2.2.1. Infection Risks Associated to Breast Biopsy Procedures
3.2.2.2. Strict Regulatory Issues
3.2.3. Opportunities
3.2.3.1. Technological Advancement in Breast Biopsy Procedures....CONTINUED FOR TOC
To Avail Discount, Please click On the Link @www.crystalmarketresearch.com/check-discount/CM10250
About Crystal Market Research:
Crystal Offers One Stop Solution For Market Research, Business Intelligence, And Consulting Services To Help Clients Make More Informed Decisions. It Provides Both Syndicated As Well As Customized Research Studies For Its Customers Spread Across The Globe. The Company Offers Market Intelligence Reports Across A Broad Range Of Industries Including Healthcare, Chemicals & Materials, Technology, Automotive, And Energy.
Contact Us:
Judy S,
304 South Jones Blvd, Suite 1896,
Las Vegas NV 89107,
United States
Toll Free: +1-888-213-4282
Email: Sales@Crystalmarketresearch.Com
No comments:
Post a Comment